Browsing Category
Buffer
Impact of antioxidant addition on drug dissolution: Implications for NDSRI mitigation biowaivers
Abstract
Nitrosamine impurities have garnered recent attention due to their presence in pharmaceuticals and their mutagenic risks. Recent studies have emphasized controlling impurities and suggest ways to mitigate the further formation of nitrosamines by the addition of antioxidants to tablets and…
Read More...
Read More...
Unlocking the potential of microfluidic assisted formulation of exenatide-loaded solid lipid…
Abstract
Exenatide, a first-in-class GLP-1 receptor agonist, is used to control glycaemic levels in type 2 diabetes. There are two approved injectable formulations: one solution for immediate action and one dispersion for prolonged action. Oral exenatide has low bioavailability due to poor…
Read More...
Read More...
Aceclofenac Delivery through Polymeric Nanoparticles loaded with Transdermal Hydrogel against…
Abstract
Hydrogels have gained attention in drug delivery systems for their ability to encapsulate nanoparticles, providing sustained and targeted release. In this study, polymeric nanoparticles (NPs) of aceclofenac (ACE) were loaded into a carbopol-based hydrogel to overcome problems associated…
Read More...
Read More...
Dynamic phase behavior of amorphous solid dispersions revealed with in situ stimulated Raman…
This study reports the application of in situ stimulated Raman scattering (SRS) microscopy for real-time chemically-specific imaging of dynamic phase phenomena in amorphous solid dispersions (ASD). Using binary ritonavir and poly(vinylpyrrolidone-vinyl acetate) films with different drug loadings…
Read More...
Read More...
Formulation of semi-solid dosage forms indented for transdermal delivery of ivermectin
The story of ivermectin originated in 1974, when scientist Satoshi Omura discovered Streptomyces avermitilis, which later led to the isolation of an active compound, avermectin and finally, ivermectin . Ivermectin, which consists of two homologs (namely dihydro-avermectin B1b and dihydro-avermectin…
Read More...
Read More...
Synergistic cryoprotective effect of deaeration and polysorbate 80 on IgG denaturation during…
Polysorbate 80 (PS80) is employed as a cryoprotectant in biotherapeutic formulations to preserve biologics from denaturation during the freezing process. However, excessive quantities of PS80 can lead to stickiness in dry powder, thereby reducing production yields and altering the physical and…
Read More...
Read More...
Could the Change of Excipient Content Improve the Stability of Gastroresistant Omeprazole Pellets?
Abstract
Omeprazole (OM), a temperature, pH, and moisture-sensitive drug, poses formulation challenges. This study delves into the complex development of OM pellets, focusing on the impact of buffering excipients on stability and release. Addressing the challenges of OM pellet stability requires a…
Read More...
Read More...
Amorphous Polymer–Phospholipid Solid Dispersions for the Co-Delivery of Curcumin and Piperine…
Curcumin and piperine are plant compounds known for their health-promoting properties, but their use in the prevention or treatment of various diseases is limited by their poor solubility. To overcome this drawback, the curcumin–piperine amorphous polymer–phospholipid dispersions were prepared by…
Read More...
Read More...
Characterization of Prototype Gummy Formulations Provides Insight into Setting Quality Standards
Gummy formulations are considered suitable alternatives to traditional oral dosage forms like tablets and capsules due to their merits that include chewability, softness/flexibility, improved drug release, administration without water, appealing organoleptic properties, better patient compliance,…
Read More...
Read More...
TABULOSE® SC colloidal microcrystalline cellulose – Key factors to consider when using TABULOSE® SC…
Introduction
Pharmaceutical suspensions can be formulated for different routes of administration, such as oral, inhalation and parenteral routes. For liquid formulations, it is considered when the drug is insoluble in the delivery vehicle, avoiding the need of co-solvents. Oral suspensions present…
Read More...
Read More...